Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175
暂无分享,去创建一个
T. Gudermann | R. Jahn | B. Nilius | R. Lill | P. D. Tombe
[1] Christopher Wilhelm,et al. Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection , 2019, 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
[2] B. Puschner,et al. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy , 2018, Journal of veterinary internal medicine.
[3] J. Li,et al. A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[4] A. Rezayan,et al. Enhanced Entrapment and Improved in Vitro Controlled Release of N‐Acetyl Cysteine in Hybrid PLGA/Lecithin Nanoparticles Prepared Using a Nanoprecipitation/Self‐Assembly Method , 2017, Journal of cellular biochemistry.
[5] P. Calder. Omega-3 fatty acids and inflammatory processes: from molecules to man. , 2017, Biochemical Society transactions.
[6] M. Sankian,et al. Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli. , 2017, Reports of biochemistry & molecular biology.
[7] R. Fontana,et al. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. , 2017, Journal of hepatology.
[8] Y. Panahi,et al. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial , 2017, Drug Research.
[9] A. Mosavat,et al. CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse , 2017, Iranian journal of basic medical sciences.
[10] R. Sadeghi,et al. Middle East Mycobacterium tuberculosis Antibiotic Resistance: A Systematic Review and Meta-Analysis , 2017 .
[11] Lei Dong,et al. Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress. , 2016, Clinical nutrition.
[12] Ruchi Bansal,et al. Clinical Advancements in the Targeted Therapies against Liver Fibrosis , 2016, Mediators of inflammation.
[13] R. Sadeghi,et al. The role of Toll-like receptor gene polymorphisms in tuberculosis susceptibility: a systematic review and meta- analysis , 2016 .
[14] Xianjun Meng,et al. Lonicera caerulea berry extract suppresses lipopolysaccharide-induced inflammation via Toll-like receptor and oxidative stress-associated mitogen-activated protein kinase signaling. , 2016, Food & function.
[15] M. Sankian,et al. Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen , 2016 .
[16] M. Pagliassotti,et al. Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. , 2016, Metabolism: clinical and experimental.
[17] S. Asgary,et al. Treatment of Non‐alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo‐controlled Trial , 2016, Phytotherapy research : PTR.
[18] Yan-Yan Zhang,et al. (-)-Epigallocatechin-3-gallate (EGCG) attenuates arsenic-induced cardiotoxicity in rats. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[19] M. Santoro,et al. ROS homeostasis and metabolism: a dangerous liason in cancer cells , 2016, Cell Death and Disease.
[20] A. Mosavat,et al. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis , 2016, Molecular Biology Reports.
[21] S. Cai,et al. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation. , 2016, Antioxidants & redox signaling.
[22] D. Rockey,et al. The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice. , 2016, International journal of physiology, pathophysiology and pharmacology.
[23] S. J. Sucheck,et al. Recent Advances in Subunit Vaccine Carriers , 2016, Vaccines.
[24] B. Jha,et al. Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma. , 2016, Cancer research.
[25] A. Mosavat,et al. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[26] M. El-Awady,et al. Pomegranate protects liver against cecal ligation and puncture-induced oxidative stress and inflammation in rats through TLR4/NF-κB pathway inhibition. , 2016, Environmental toxicology and pharmacology.
[27] Hyung-Ryong Kim,et al. Endoplasmic Reticulum Stress and Associated ROS , 2016, International journal of molecular sciences.
[28] Z. Beck,et al. Liposomal adjuvants for human vaccines , 2016, Expert opinion on drug delivery.
[29] Q. Wang,et al. A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis , 2016, Human vaccines & immunotherapeutics.
[30] D. Brenner,et al. The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts , 2016, Front. Physiol..
[31] H. Forman,et al. Redox homeostasis: The Golden Mean of healthy living , 2016, Redox biology.
[32] C. Aiken,et al. Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth1 , 2015, The American journal of clinical nutrition.
[33] Youming Li,et al. Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis , 2015, Journal of clinical biochemistry and nutrition.
[34] J. Chen,et al. NIM811 downregulates transforming growth factor‑β signal transduction in vivo and in vitro. , 2016, Molecular medicine reports.
[35] J. Demarquoy,et al. Crosstalk between mitochondria and peroxisomes. , 2015, World journal of biological chemistry.
[36] Tilman Grune,et al. Clinical Relevance of Biomarkers of Oxidative Stress , 2015, Antioxidants & redox signaling.
[37] A. Mosavat,et al. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice , 2015, Applied Microbiology and Biotechnology.
[38] Kamil Kuča,et al. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease , 2015, Archives of Toxicology.
[39] Zhang-Chun Li,et al. Quercetin protects mouse liver against CCl₄-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway. , 2015, International immunopharmacology.
[40] D. Jump,et al. Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice , 2015, Proceedings of the Nutrition Society.
[41] D. Brenner,et al. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation , 2015, PloS one.
[42] Shuijun Zhang,et al. Protective Effects of Salubrinal on Liver Injury in Rat Models of Brain Death , 2015, Chinese medical journal.
[43] R. Brosch,et al. Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. , 2015, Vaccine.
[44] C. Trautwein,et al. Hepatic fibrosis: Concept to treatment. , 2015, Journal of hepatology.
[45] Abolghasem Jouyban,et al. Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders , 2015, BioImpacts : BI.
[46] F. Gonzalez,et al. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy , 2015, BBA clinical.
[47] Fang Yuan,et al. Minocycline protects against hepatic ischemia/reperfusion injury in a rat model. , 2015, Biomedical reports.
[48] S. Batra,et al. NADPH oxidases: an overview from structure to innate immunity-associated pathologies , 2014, Cellular and Molecular Immunology.
[49] R. Sarhan,et al. Biochemical assessment of oxidative status versus liver enzymes in patients with chronic fascioliasis , 2015, Journal of Parasitic Diseases.
[50] Mona F. Mahmoud,et al. Limonin attenuates hepatocellular injury following liver ischemia and reperfusion in rats via toll-like receptor dependent pathway. , 2014, European journal of pharmacology.
[51] Joo Yeon Park,et al. Nanotechnology and vaccine development , 2014 .
[52] P. Calder,et al. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study , 2014, Hepatology.
[53] M. Farhangi,et al. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. , 2014, Archives of medical research.
[54] D. O'hagan,et al. Designing and building the next generation of improved vaccine adjuvants. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[55] M. Ehrich,et al. In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters , 2014, Nanoscale Research Letters.
[56] D. H. Kim,et al. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro. , 2014, Life sciences.
[57] R. Schwendener,et al. Liposomes as vaccine delivery systems: a review of the recent advances , 2014, Therapeutic advances in vaccines.
[58] H. Cichoż-Lach,et al. Oxidative stress as a crucial factor in liver diseases. , 2014, World journal of gastroenterology.
[59] S. Kaufmann,et al. Novel vaccination strategies against tuberculosis. , 2014, Cold Spring Harbor perspectives in medicine.
[60] G. Zhai,et al. Recent advances in active hepatic targeting drug delivery system. , 2014, Current drug targets.
[61] Jamey D. Young,et al. ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload , 2014, Molecular metabolism.
[62] N. Chandel,et al. ROS Function in Redox Signaling and Oxidative Stress , 2014, Current Biology.
[63] F. Nassir,et al. Role of Mitochondria in Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.
[64] Yujun Jiang,et al. Protective Effects of Lactobacillus plantarum NDC 75017 Against Lipopolysaccharide-Induced Liver Injury in Mice , 2014, Inflammation.
[65] H. Qian,et al. Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice , 2014, Archives of Pharmacal Research.
[66] F. Nassir,et al. Role of mitochondria in alcoholic liver disease. , 2014, World journal of gastroenterology.
[67] S. Xiong,et al. A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection , 2014, Human vaccines & immunotherapeutics.
[68] E. Niki. Biomarkers of lipid peroxidation in clinical material. , 2014, Biochimica et biophysica acta.
[69] Y. Perrie,et al. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl‐sn‐glycero‐3‐phosphocholine content in liposomal adjuvants , 2013, The Journal of pharmacy and pharmacology.
[70] D. Vecchio,et al. Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells. , 2013, Free radical biology & medicine.
[71] L. Wojtczak,et al. Interaction of the antibiotic minocycline with liver mitochondria – role of membrane permeabilization in the impairment of respiration , 2013, The FEBS journal.
[72] L. Zhuo,et al. Asiatic acid from Potentilla chinensis attenuate ethanol-induced hepatic injury via suppression of oxidative stress and Kupffer cell activation. , 2013, Biological & pharmaceutical bulletin.
[73] P. Fischer,et al. Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice , 2013, Science Translational Medicine.
[74] S. Geary,et al. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses , 2013, Human vaccines & immunotherapeutics.
[75] Hongjuan Yu,et al. Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice , 2013, PloS one.
[76] H. McShane,et al. Vaccination against tuberculosis: how can we better BCG? , 2013, Microbial pathogenesis.
[77] B. Zhu,et al. Systems approach to tuberculosis vaccine development , 2013, Respirology.
[78] S. Kaufmann. Tuberculosis vaccines: time to think about the next generation. , 2013, Seminars in immunology.
[79] Laura J. Dixon,et al. Kupffer cells in the liver. , 2013, Comprehensive Physiology.
[80] Kenneth A. Philbrick,et al. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. , 2013, The Journal of nutrition.
[81] B. Bartosch,et al. Hepatitis C Virus-Induced Mitochondrial Dysfunctions , 2013, Viruses.
[82] A. Zorzano,et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. , 2013, International review of cell and molecular biology.
[83] Jian-Gao Fan,et al. Randomized, Vitamin E-Controlled Trial of Bicyclol Plus Metformin in Non-Alcoholic Fatty Liver Disease Patients with Impaired Fasting Glucose , 2013, Clinical Drug Investigation.
[84] A. Khamesipour,et al. The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen. , 2012, Experimental parasitology.
[85] N. Chavez-Tapia,et al. Role of oxidative stress and molecular changes in liver fibrosis: a review. , 2012, Current medicinal chemistry.
[86] C. Hoppel,et al. Oxidation of Fatty Acids Is the Source of Increased Mitochondrial Reactive Oxygen Species Production in Kidney Cortical Tubules in Early Diabetes , 2012, Diabetes.
[87] M. H. Santana,et al. Effectiveness, against tuberculosis, of pseudo-ternary complexes: peptide-DNA-cationic liposome. , 2012, Journal of colloid and interface science.
[88] S. Kaufmann,et al. Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? , 2012, PLoS pathogens.
[89] J. Kong,et al. Oxidative stress in neurodegenerative diseases , 2012, Neural regeneration research.
[90] Hongjuan Yu,et al. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. , 2011, Vaccine.
[91] H. McShane,et al. Tuberculosis vaccines: progress and challenges. , 2011, Trends in pharmacological sciences.
[92] O. Firuzi,et al. Antioxidant therapy: current status and future prospects. , 2011, Current medicinal chemistry.
[93] S. Malik,et al. HEPATOPROTECTIVE EFFECTS OF BERBERIS LYCIUM, GALIUM APARINE AND PISTACIA INTEGERRIMA IN CARBON TETRACHLORIDE (CCL4)-TREATED RATS , 2011 .
[94] Amal A. Baalash,et al. Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats , 2011, Diabetology & metabolic syndrome.
[95] K. Tsai,et al. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model. , 2011, Free radical biology & medicine.
[96] Y. Zhang,et al. Immunogenicity and Protective Efficacy of a Fusion Protein Vaccine Consisting of Antigen Ag85B and HspX against Mycobacterium tuberculosis Infection in Mice , 2011, Scandinavian journal of immunology.
[97] P. Portincasa,et al. Mitochondria in chronic liver disease. , 2011, Current drug targets.
[98] Y. Perrie,et al. Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. , 2011, Journal of pharmaceutical sciences.
[99] N. Garçon,et al. Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems , 2011, Expert review of vaccines.
[100] Sang-Nae Cho,et al. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. , 2011, Microbes and infection.
[101] N. Gu,et al. Cationic liposomes as gene delivery system: transfection efficiency and new application. , 2011, Die Pharmazie.
[102] J. Praestgaard,et al. Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy. , 2011, Antiviral research.
[103] Hasibur Rehman,et al. NIM811 Prevents Mitochondrial Dysfunction, Attenuates Liver Injury, and Stimulates Liver Regeneration After Massive Hepatectomy , 2010, Transplantation.
[104] Ferdinando Giacco,et al. Oxidative stress and diabetic complications. , 2010, Circulation research.
[105] M. Macías-Silva,et al. Angiotensin II increases mRNA levels of all TGF‐β isoforms in quiescent and activated rat hepatic stellate cells , 2010, Cell biology international.
[106] Robin A. J. Smith,et al. The mitochondria‐targeted anti‐oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[107] T. Billiar,et al. Linking oxidative stress to inflammation: Toll-like receptors. , 2010, Free radical biology & medicine.
[108] T. Waldmann,et al. Highly Persistent and Effective Prime/Boost Regimens against Tuberculosis That Use a Multivalent Modified Vaccine Virus Ankara-Based Tuberculosis Vaccine with Interleukin-15 as a Molecular Adjuvant , 2010, Clinical and Vaccine Immunology.
[109] L. Rajendran,et al. Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.
[110] Yuba Raj Pokharel,et al. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. , 2009, Toxicology and applied pharmacology.
[111] Hongjuan Yu,et al. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. , 2009, Vaccine.
[112] D. Brenner,et al. Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[113] F. Gonzalez,et al. Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. , 2009, Journal of hepatology.
[114] J. Christensen,et al. CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination , 2009, PloS one.
[115] Michael P. Murphy,et al. How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.
[116] C. Leclerc,et al. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. , 2009, Vaccine.
[117] Yeong Shik Kim,et al. Chlorogenic acid, a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans. , 2008, International immunopharmacology.
[118] P. Andersen,et al. Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements , 2008, PloS one.
[119] S. Ramos,et al. Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes , 2008, BMC Immunology.
[120] Jing Zhao,et al. Protective effect of bicyclol on acute alcohol-induced liver injury in mice. , 2008, European journal of pharmacology.
[121] C. Russell Middaugh,et al. Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.
[122] Y. Perrie,et al. PLGA microspheres for the delivery of a novel subunit TB vaccine. , 2008, Journal of drug targeting.
[123] M. Rosengart,et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.
[124] E. Agger,et al. Cationic liposomes as vaccine adjuvants , 2007, Expert review of vaccines.
[125] N. Kawada,et al. Role of oxidative stress and Kupffer cells in hepatic fibrosis , 2007, Journal of gastroenterology and hepatology.
[126] P. Andersen. Vaccine strategies against latent tuberculosis infection. , 2007, Trends in microbiology.
[127] J. Pincemail,et al. [Oxidative stress]. , 2007, Revue medicale de Liege.
[128] F. Szoka,et al. Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.
[129] N. Nieto. Oxidative‐stress and IL‐6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells , 2006, Hepatology.
[130] Leaf Huang,et al. Immunostimulation of dendritic cells by cationic liposomes , 2006, Molecular membrane biology.
[131] M. Kieny,et al. A review of vaccine research and development: tuberculosis. , 2005, Vaccine.
[132] P. Andersen,et al. Cationic Liposomes Containing Mycobacterial Lipids: a New Powerful Th1 Adjuvant System , 2005, Infection and Immunity.
[133] G. Khuller,et al. Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. , 2005, Vaccine.
[134] H. Cai,et al. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. , 2005, Vaccine.
[135] A. Thomas,et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. , 2005, Vaccine.
[136] Min-Seon Kim,et al. alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. , 2004, Biochemical and biophysical research communications.
[137] Takahiro Suzuki,et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.
[138] Ann Williams,et al. Protective Effect of a Tuberculosis Subunit Vaccine Based on a Fusion of Antigen 85B and ESAT-6 in the Aerosol Guinea Pig Model , 2004, Infection and Immunity.
[139] H. Park,et al. Cutting Edge: Direct Interaction of TLR4 with NAD(P)H Oxidase 4 Isozyme Is Essential for Lipopolysaccharide-Induced Production of Reactive Oxygen Species and Activation of NF-κB1 , 2004, The Journal of Immunology.
[140] R. Glück,et al. Influenza virosomes as an efficient system for adjuvanted vaccine delivery , 2004, Expert opinion on biological therapy.
[141] P. Andersen,et al. Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines , 2004, Infection and Immunity.
[142] G. Gores,et al. The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse , 2004, Journal of Pharmacology and Experimental Therapeutics.
[143] L. Videla,et al. Oxidative stress-mediated hepatotoxicity of iron and copper: Role of Kupffer cells , 2003, Biometals.
[144] Norazmi Mohd Nor,et al. Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine. , 2004, Tuberculosis.
[145] M. Robin,et al. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. , 2004, Diabetes.
[146] A. Parrish,et al. The role of hepatocellular oxidative stress in Kupffer cell activation during 1,2-dichlorobenzene-induced hepatotoxicity. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[147] G. Kitas,et al. Validation of a novel ELISA for measurement of MDA-LDL in human plasma. , 2003, Free radical biology & medicine.
[148] I. Alexa,et al. [Oxidative stress in atherosclerosis]. , 2003, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.
[149] Mitsuru Hashida,et al. Factors affecting drug and gene delivery: effects of interaction with blood components. , 2002, Critical reviews in therapeutic drug carrier systems.
[150] D. Johns,et al. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. , 2002, American journal of physiology. Heart and circulatory physiology.
[151] G. Robino,et al. Oxidative stress-related molecules and liver fibrosis. , 2001, Journal of hepatology.
[152] P. Andersen,et al. Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6 , 2001, Infection and Immunity.
[153] H. Zhu,et al. Mitochondrial adaptations to obesity-related oxidant stress. , 2000, Archives of biochemistry and biophysics.
[154] K. Hensley,et al. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. , 2000, Carcinogenesis.
[155] David C. Jones,et al. C ASE R EPORT: Oral antioxidant therapy for the treatment of primary biliary cirrhosis: A pilot study , 1999, Journal of gastroenterology and hepatology.
[156] A. Boveris,et al. Primary role of Kupffer cell–hepatocyte communication in the expression of oxidative stress in the post‐ischaemic liver , 1998, Cell biochemistry and function.
[157] F. Ridolfi,et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells , 1998, Hepatology.
[158] S. Sherlock,et al. Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial. , 1980, Gut.